Exegiline Pharma

Exegiline Pharma Overview

Exegiline Pharma is developing a novel multifunctional oral drug, MT-031, for the treatment of dementia and Alzheimer's disease. MT-031's structure combines rivastigmine (Exelon) and rasagiline (Azilect) moieties and has the beneficial properties of both and more. It works as a dual acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitor as well a selective irreversible inhibition of MAO-A. MT-031 has a brain-permeable novel multifunctional MAO-AChE/BuChe inhibitor, anti-inflammatory properties, neuroprotective activity, and cognitive- and memory-enhancing activities. The molecule and its indications are protected by US and European patents. The company was established at Youdim Pharmaceuticals, a pharmaceutical company and incubator.

Cumulative Funding Raised Over Time ($)

Latest News

Apr 22, 2022 · www.jpost.com

growth-positive

In Parkinson's Awareness Month, Parkinson's pioneer wins Israel Prize

Youdim Pharmaceuticals, led by Prof. Emeritus Moussa Youdim and his son Tal Youdim, is making significant strides in developing treatments for neurodegenerative diseases such as Parkinsons and Alzheimers. The company has developed innovative drugs and devices, including the Endopump and multitarget drug MT-031. The Endopump, a streamlined drug delivery device, has shown promising results in animal studies and is set to enter the next stage of development with a major medical device company. Additionally, MT-031 aims to treat dementia and depression in neurodegenerative patients. The company is currently fundraising $5-10 million for preclinical trials. Moussa Youdim was recently awarded the 2022 Israel Prize in Life Sciences for his groundbreaking work.

InvestmentPartners

Funding

Team Members

4

Employees: 1-10

Web & Social Links

Locations

Ha-Tsmikha Street 1, Yokne'am Illit, Israel

Photos & Videos

No files yet

Exegiline Pharma Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info